These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16569635)

  • 1. Probing the conformation of the prion protein within a single amyloid fibril using a novel immunoconformational assay.
    Novitskaya V; Makarava N; Bellon A; Bocharova OV; Bronstein IB; Williamson RA; Baskakov IV
    J Biol Chem; 2006 Jun; 281(22):15536-45. PubMed ID: 16569635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of soluble oligomers and amyloid fibrils with physical properties of the scrapie isoform of the prion protein from the C-terminal domain of recombinant murine prion protein mPrP-(121-231).
    Martins SM; Frosoni DJ; Martinez AM; De Felice FG; Ferreira ST
    J Biol Chem; 2006 Sep; 281(36):26121-8. PubMed ID: 16844683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prion protein amyloid formation under native-like conditions involves refolding of the C-terminal alpha-helical domain.
    Cobb NJ; Apetri AC; Surewicz WK
    J Biol Chem; 2008 Dec; 283(50):34704-11. PubMed ID: 18930924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autocatalytic conversion of recombinant prion proteins displays a species barrier.
    Baskakov IV
    J Biol Chem; 2004 Feb; 279(9):7671-7. PubMed ID: 14668351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-specific conformational studies of prion protein (PrP) amyloid fibrils revealed two cooperative folding domains within amyloid structure.
    Sun Y; Breydo L; Makarava N; Yang Q; Bocharova OV; Baskakov IV
    J Biol Chem; 2007 Mar; 282(12):9090-7. PubMed ID: 17244617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissection of conformational conversion events during prion amyloid fibril formation using hydrogen exchange and mass spectrometry.
    Singh J; Udgaonkar JB
    J Mol Biol; 2013 Sep; 425(18):3510-21. PubMed ID: 23811055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational stability of PrP amyloid fibrils controls their smallest possible fragment size.
    Sun Y; Makarava N; Lee CI; Laksanalamai P; Robb FT; Baskakov IV
    J Mol Biol; 2008 Feb; 376(4):1155-67. PubMed ID: 18206163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid formation by recombinant full-length prion proteins in phospholipid bicelle solutions.
    Lührs T; Zahn R; Wüthrich K
    J Mol Biol; 2006 Mar; 357(3):833-41. PubMed ID: 16466741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the prion protein using recombinant antibodies.
    Williamson RA; Peretz D; Pinilla C; Ball H; Bastidas RB; Rozenshteyn R; Houghten RA; Prusiner SB; Burton DR
    J Virol; 1998 Nov; 72(11):9413-8. PubMed ID: 9765500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-Replication of Prion Protein Fragment 89-230 Amyloid Fibrils Accelerated by Prion Protein Fragment 107-143 Aggregates.
    Sneideris T; Ziaunys M; Chu BK; Chen RP; Smirnovas V
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33049945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogen/deuterium exchange mass spectrometry identifies two highly protected regions in recombinant full-length prion protein amyloid fibrils.
    Nazabal A; Hornemann S; Aguzzi A; Zenobi R
    J Mass Spectrom; 2009 Jun; 44(6):965-77. PubMed ID: 19283723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How does domain replacement affect fibril formation of the rabbit/human prion proteins.
    Yan X; Huang JJ; Zhou Z; Chen J; Liang Y
    PLoS One; 2014; 9(11):e113238. PubMed ID: 25401497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methionine oxidation interferes with conversion of the prion protein into the fibrillar proteinase K-resistant conformation.
    Breydo L; Bocharova OV; Makarava N; Salnikov VV; Anderson M; Baskakov IV
    Biochemistry; 2005 Nov; 44(47):15534-43. PubMed ID: 16300402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid-liquid phase separation of full-length prion protein initiates conformational conversion in vitro.
    Tange H; Ishibashi D; Nakagaki T; Taguchi Y; Kamatari YO; Ozawa H; Nishida N
    J Biol Chem; 2021; 296():100367. PubMed ID: 33545172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assemblages of prion fragments: novel model systems for understanding amyloid toxicity.
    Satheeshkumar KS; Murali J; Jayakumar R
    J Struct Biol; 2004 Nov; 148(2):176-93. PubMed ID: 15477098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annealing prion protein amyloid fibrils at high temperature results in extension of a proteinase K-resistant core.
    Bocharova OV; Makarava N; Breydo L; Anderson M; Salnikov VV; Baskakov IV
    J Biol Chem; 2006 Jan; 281(4):2373-9. PubMed ID: 16314415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathway complexity of prion protein assembly into amyloid.
    Baskakov IV; Legname G; Baldwin MA; Prusiner SB; Cohen FE
    J Biol Chem; 2002 Jun; 277(24):21140-8. PubMed ID: 11912192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly promiscuous nature of prion polymerization.
    Makarava N; Lee CI; Ostapchenko VG; Baskakov IV
    J Biol Chem; 2007 Dec; 282(50):36704-13. PubMed ID: 17940285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shaking alone induces de novo conversion of recombinant prion proteins to β-sheet rich oligomers and fibrils.
    Ladner-Keay CL; Griffith BJ; Wishart DS
    PLoS One; 2014; 9(6):e98753. PubMed ID: 24892647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational variation between allelic variants of cell-surface ovine prion protein.
    Thackray AM; Yang S; Wong E; Fitzmaurice TJ; Morgan-Warren RJ; Bujdoso R
    Biochem J; 2004 Jul; 381(Pt 1):221-9. PubMed ID: 15070397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.